Pain and Disability Outcomes in Post Amputation Patients

Sponsor
Milton S. Hershey Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05716321
Collaborator
(none)
350
1
33
10.6

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate efficacy of varied medical and procedural therapies used to treat pain after surgical amputation of a limb. The primary outcome will be assessment of pain severity at rest and with movement as measured by pain scores on Numerical Rating Scale (NRS) 0 to 10, where 0 is not pain and 10 is the worst pain possible, taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The objective of this study is to evaluate efficacy of varied medical and procedural therapies used to treat pain for surgical amputation of a limb.

    At present there are number of different type of therapies are performed in the patients who is going through an amputation of any limb for management of their pain adequately such as peripheral nerve block, epidurals, peripheral nerve stimulators etc. However, the effects of these different procedures performed at different time intervals have not been evaluated for their effects on phantom pain and somatic pain long term after the procedures in these group of patients.

    We will be collecting the following data from these patients to see if there is any particular intervention done at particular time of the procedure ( before the amputation vs. after the amputation) affect the long term outcome of these patients such as development of Phantom pain, or chronic pain

    The primary outcome will be assessment of pain severity at rest and with movement as measured by pain scores on Numerical Rating Scale (NRS) 0 to 10, where 0 is not pain and 10 is the worst pain possible, taken on postoperative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point).

    The secondary outcomes will be 1) phantom limb pain severity as rated on NRS 2) Residual limb (stump) pain as rated on NRS 3) phantom limb sensations 4) Pain Disability Index scores 5) Morphine milligram equivalents. These secondary outcomes will be assessed at the same intervals as the primary outcome.

    This study will help us to find out if there is any utility of any of these procedures performed at particular time of the procedure helps them more than the others for development of somatic or phantom pain.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    350 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Pain and Disability Outcomes in Post Amputation Patients
    Anticipated Study Start Date :
    Feb 1, 2023
    Anticipated Primary Completion Date :
    Nov 1, 2024
    Anticipated Study Completion Date :
    Nov 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Change in Pain Severity at rest and movement [1 year]

      The primary outcome will be assessment of pain severity at rest and with movement as measured by pain scores on Numerical Rating Scale (NRS) 0 to 10 taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point). 0 means no pain and 10 means the worst pain ever.

    Secondary Outcome Measures

    1. Using NRS to rate phantom limb pain change in severity [1 year]

      The secondary outcomes will be phantom limb pain severity as rated on NRS. 0 to 10 taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point). 0 means no pain and 10 means the worst pain ever.

    2. Using NRS to rate severity of change in pain [1 year]

      The third outcomes will be Residual limb (stump) pain as rated on NRS. 0 to 10 taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point). 0 means no pain and 10 means the worst pain ever.

    3. Using NRS to rate of change in severity of Phantom limb sensations. [1 year]

      The fourth outcomes will be phantom limb sensations. 0 to 10 taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point). 0 means no sensation and 10 means the worst feeling ever.

    4. Using NRS to rate Pain Disabiliy [1 year]

      The Fifth outcomes will be Pain Disability Index scores. 0 to 10 taken on post-operative day 1, day 7, 30 days, 90 days, 6 months, and 1 year (+/- 3 days at each time point). of 0 means no disability at all, and a score of 10 signifies that all of the activities in which you would normally be involved have been totally disrupted or prevented by your pain.

    5. The amount of pain medication used. [1 year]

      The sixth outcomes will be the amount of Morphine milligram equivalents. The amount taken on post-operative day 1, Day 1 to day 7, day 8 to 30 days, 31 days to 90 days, 91 days to 6 months, and from 6 months to 1 year (+/- 3 days at each time point).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 89 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Ages between 18 and 89 years old, inclusive

    2. Patients scheduled for surgical limb amputation at Penn State Hershey Medical Center

    Exclusion Criteria:
    1. Patients who cannot cooperate or consent

    2. Patients who cannot understand or speak English

    3. Patients with a history of chronic regional pain syndromes

    4. Patients suffering from alcohol and/or drug abuse -based on previous Dx listed in the MRN

    5. BMI >50

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033

    Sponsors and Collaborators

    • Milton S. Hershey Medical Center

    Investigators

    • Principal Investigator: Sanjib Adhikary, M.B.B.S., MD, Milton S. Hershey Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sanjib D Adhikary, Professor of Anesthesiology,, Milton S. Hershey Medical Center
    ClinicalTrials.gov Identifier:
    NCT05716321
    Other Study ID Numbers:
    • STUDY20483
    First Posted:
    Feb 8, 2023
    Last Update Posted:
    Feb 9, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sanjib D Adhikary, Professor of Anesthesiology,, Milton S. Hershey Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 9, 2023